Parkway Life Real Estate Investment Trust (PRKWF)
Parkway Life Real Estate Investment Trust operates in the REIT - Healthcare Facilities industry of the Real Estate sector, headquartered in Singapore, CE, SG. The stock last traded at $2.90, up 0.00% on the session, giving a market capitalisation of $1.89B. On trailing twelve-month figures it carries a trailing P/E of 15.56, a net margin of 106.5%. Its beta of 0.38 implies it has historically moved less than the broad market.
Parkway Life Real Estate Investment Trust (PLife REIT) stands as one of Asia's most prominent publicly listed healthcare REITs, judging by the size of its assets. Its investment strategy is centered on acquiring revenue-generating real estate and related assets primarily intended for healthcare or associated purposes. This broad definition encompasses facilities like hospitals and various medical centers, as well as properties utilized for healthcare research, educational activities, and the manufacturing or warehousing of pharmaceuticals, medical devices, and other healthcare products. As of December 31, 2020, PLife REIT boasted a diverse portfolio of 54 properties located across the Asia Pacific region, collectively valued at approximately S$2.02 billion. Its Singaporean holdings are particularly notable, comprising the largest array of strategically situated private hospitals, including Mount Elizabeth Hospital, Gleneagles Hospital, and Parkway East Hospital. Complementing these are 50 high-standard nursing homes and care facilities spread across numerous prefectures in Japan. Moreover, the trust holds strata-titled units within the MOB Specialist Clinics building in Kuala Lumpur, Malaysia.
Parkway Life Real Estate Investment Trust is most often compared with the following Real Estate names: